Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Rhea-AI Summary

Haemonetics (NYSE: HAE) released its financial results for the fourth quarter and fiscal year 2024, accessible on its Investor Relations website. The company will host a conference call and webcast to discuss the results. Links to the earnings release and analytical tables are available on the website.

Insights

Financial Analyst

Haemonetics Corporation's announcement regarding its fourth quarter and fiscal year 2024 financial results merits attention, notably as it relates to the performance of the company vis-a-vis industry benchmarks and investor expectations. The release and accompanying analytical tables offer insights into Haemonetics' revenue streams and financial health. A critical evaluation of the revenue recast could reveal trends that may affect future profitability, such as shifts towards more stable or high-margin segments. Furthermore, discrepancies in growth rates compared to peers can surface strategic advantages or operational issues. Investors should gauge these results against previous quarters and fiscal years to ascertain consistency in financial policy and execution. The available data, when scrutinized, can serve as a barometer for forecasting the company's ability to generate shareholder value, manage debt and invest in growth opportunities. It's prudent to monitor how management communicates these results during the conference call as their tone and commentary could provide additional context.

Market Research Analyst

From a market perspective, the fiscal results of Haemonetics are pivotal in appraising the company's current market position and competitive edge. The recast historical revenue information might indicate strategic shifts or an evolving market focus that could realign the company's trajectory. Analyzing industry-specific response to such restructurings can illuminate potential market opportunities or risks, particularly if Haemonetics is deviating from conventional practices. Investors can utilize this information to deduce whether the company is better positioned than its competitors to capitalize on market trends or if it is falling behind. This insight is important in assessing the potential for market share gains or losses, which directly correlates to the stock's future performance. It's also beneficial to consider the broader economic environment as it can significantly influence the purchasing patterns of Haemonetics' customers, which in turn affects company revenues.

Financial release accessible online

BOSTON, May 9, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter and fiscal year 2024, which ended March 30, 2024, are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 9, 2024. The conference call and webcast can be accessed with the following information:

• Teleconference link:
  https://register.vevent.com/register/BI7654787bc47144b39cb181c1abab0531 
• Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
• A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/5cppxurr

In addition, the Company has posted to its Investor Relations website the earnings release and certain supplemental analytical tables including two years of historical revenue information recast in the updated revenue reporting structure that will be referenced on its conference call and webcast, links to which are available below. 

Direct link to 4Q FY24 Earnings Release:
https://haemonetics.gcs-web.com/static-files/4c58f1e8-c0ed-46e7-89b4-99a6d4dc53c6

Direct link to Service Revenue Reporting Change Analytical Tables:
https://haemonetics.gcs-web.com/static-files/e6895d75-dd6f-4f9f-af30-387bd364b386 

A replay of the conference call and webcast will be available for one year beginning on May 9, 2024, at 11:00 a.m. ET using the conference call webcast link provided in this press release.

About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:         
Olga Guyette, Sr. Director-Investor Relations & Treasury 
(781) 356-9763       
olga.guyette@haemonetics.com      

David Trenk, Manager-Investor Relations 
(203) 733-4987
david.trenk@haemonetics.com                                                                               

Media Contact:             
Josh Gitelson, Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-4th-quarter-and-fiscal-year-2024-earnings-release-available-on-investor-relations-website-302140225.html

SOURCE Haemonetics Corporation

FAQ

When did Haemonetics release its financial results for the fourth quarter and fiscal year 2024?

Haemonetics released its financial results for the fourth quarter and fiscal year 2024 on May 9, 2024.

Where can investors access the financial results and related information?

Investors can access the financial results and related information on Haemonetics' Investor Relations website.

When will the conference call and webcast to discuss the financial results take place?

The conference call and webcast to discuss the financial results will take place at 8:00 a.m. ET on May 9, 2024.